Labshake search
Citations for R&D Systems :
701 - 750 of 1327 citations for 3RS 4 Dimethylamino 3 methyl 2 2 diphenylbutanenitrile Isodidiavalo since 2020
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Microbiology 2021Quote: ... Memory CD4+ T-cells were infected with HIV-1 (50 ng HIV-p24/106 cells) and then cultured in the presence of IL-2 (5 ng/ml; R&D Systems, Minneapolis, MN, USA) for up to 9 days ...
-
bioRxiv - Pharmacology and Toxicology 2021Quote: ... and incubated with recombinant SARS-CoV-2 Spike protein receptor binding domain (RBD) fused to the human IgG1 Fc domain (R&D Systems 10499-CV-100) or control recombinant human IgG1 Fc protein (R&D Systems 10499-CV-100 ...
-
bioRxiv - Immunology 2020Quote: ... For iTreg cell differentiation we additionally added the following cytokines and blocking antibodies: rmIL-2 and rmTGF-β (both: R&D Systems, 5 ng/ml), anti-IL-4 (clone ...
-
bioRxiv - Immunology 2022Quote: ... Fecal LCN2 levels in the supernatant fraction were estimated using a Duoset murine LCN-2 ELISA kit (R&D Systems DY1857-05, Minneapolis, MN, USA) based on provided directions.
-
bioRxiv - Physiology 2022Quote: ... and phospho-JNK (T183/Y185 for JNK1/2 and T221/Y223 for JNK3) with commercial kits (DuoSet IC ELISA, R&D Systems, # DYC1018B and # DYC1387B) according to manufacturer’s instructions ...
-
bioRxiv - Cell Biology 2022Quote: ... hMEC 3D acini were resuspended in 10 mg/ml Cultrex Reduced Growth Factor Basement Membrane Extract (BME) Type 2 (R&D Systems, #3532-005-02) and 25 μl BME domes were plated in each well of µ-Slides 8 (Ibidi) ...
-
bioRxiv - Developmental Biology 2024Quote: ... and cells were resuspended in 1 part Advanced DMEM/F12 and 2 parts Cultrex Reduced Growth Factor Basement Membrane Extract (R&D Systems; 3533-010-02) for a final solution of 66% Cultrex ...
-
bioRxiv - Microbiology 2023Quote: ... organoids were mechanically disrupted into single cells and plated in droplets of Cultrex growth factor reduced BME type 2 (Biotechne | R&D systems 3533-010-02). For the 2D culture of airway organoids ...
-
bioRxiv - Bioengineering 2023Quote: ... Ang-2 and MCP-1 were measured from individual samples following the manufacturer’s protocols of respective Quantikine ELISA Kits (R&D systems, DVE00, DANG20 and DCP00). Cytokine expression profiles of 2D cultures were assessed using a human angiogenesis antibody array (Abcam) ...
-
bioRxiv - Immunology 2023Quote: ... the cells were washed 2x with cold PBS + 2% FBS and stained with anti-CD127-Alexa Fluor® 488 (anti-IL-7Rα) (antibody clone 40131; R&D Systems Cat# FAB306G) for 30 min on ice ...
-
bioRxiv - Bioengineering 2024Quote: ... were transferred into Neural Induction Media (NIM) composed of DMEM/F-12 supplemented with 1x N-2 MAX Media Supplement (R&D Systems, Cat no. AR009), 1x GlutaMAX ...
-
bioRxiv - Developmental Biology 2024Quote: ... washed gently three times with warm DMEM-F12 and refed with mTeSR without ROCKi for 2 hours followed with mTeSR containing 50ng/ml BMP4 (R&D systems, #314-BP-010) for 42-48 hours ...
-
bioRxiv - Cancer Biology 2024Quote: ... or 5 days (SCLC cell lines) to allow for at least 2 cell doublings before processing in an MTT proliferation assay (R&D systems, #4890-050-K) performed according to manufacturer instructions ...
-
bioRxiv - Microbiology 2024Quote: ... cell staining was done using the following conjugated antibodies and their IgG controls: Allophycocyanin (APC)-conjugated mouse IgG2a anti-human Neuropilin-2 (R&D systems, catalog no. FAB22151A) with allophycocyanin (APC)-conjugated mouse IgG2a control (R&D systems ...
-
bioRxiv - Developmental Biology 2024Quote: ... The hPSCs were plated at ∼4x104 cells/cm2 and allowed to grow for 2 days before changing with “Day 0 medium” consisting of the “base medium” plus 20 ng/mL BMP4 (R&D Systems 314-BP-050), 30 ng/mL Activin A (R&D Systems 338-AC-050) ...
-
bioRxiv - Bioengineering 2024Quote: HLOs in BME-2 were either collected manually by pipetting in cold PBS-/- or isolated from BME-2 using Cultrex organoid harvesting solution (R&D Systems; 3700-100-01) according to the manufacturer’s protocol ...
-
bioRxiv - Cell Biology 2024Quote: ... Sections were incubated at room temperature for 2 hours with primary antibodies (Megalin/LRP2, MyBiosource MBS690201, 1:500) (KIM-1, R&D Systems MAB1817, 1:250) in block solution ...
-
bioRxiv - Bioengineering 2024Quote: ... and 10ng/ml of Bone Morphogenic Protein-4 (BMP-4: R&D system, #314-BP-050) on differentiation days 1 ─ 2 to initiate differentiation ...
-
bioRxiv - Immunology 2020Quote: ... recombinant IL-4 (R&D systems), and anti-CD40 (ThermoFisher ...
-
bioRxiv - Cancer Biology 2024Quote: ... Anti-4-HNE (R&D Systems) was used with an AF647 secondary antibody (Invitrogen ...
-
bioRxiv - Molecular Biology 2024Quote: ... 10 ng/ml human interleukin-3 (IL-3) and 10 ng/ml human interleukin-6 (IL-6) (R&D Systems).
-
bioRxiv - Developmental Biology 2021Quote: ... 3 µM ZM306416 (R&D Systems, 2499/1) and 10 µM of SU5402 (R&D Systems ...
-
bioRxiv - Immunology 2021Quote: ... at 3 μM and necrosulfonamide (R&D systems) at 1 μM ...
-
bioRxiv - Genomics 2021Quote: ... or 3 ng/ml TGFB (R&D Systems), or both ...
-
bioRxiv - Immunology 2022Quote: ... anti-IFN-λ2-3 (MAB17892; R&D systems) and anti-IFNAR1 (BE00241 ...
-
bioRxiv - Neuroscience 2021Quote: ... goat anti-Galectin-3 (R&D Systems, AF1154), goat anti-GPNMB (R&D Systems ...
-
bioRxiv - Immunology 2020Quote: ... at 3 μM and necrosulfonamide (R&D systems) at 1 μM ...
-
bioRxiv - Immunology 2020Quote: ... TGF-β (3 ng/ml, R&D Systems) and Retinoic Acid (RA ...
-
bioRxiv - Physiology 2022Quote: ... rhuIL-3 (1 ng/ml, R&D Systems). Erythropoiesis was induced by addition of 3 U/ml recombinant human erythropoietin (rEPO ...
-
bioRxiv - Microbiology 2022Quote: ... and cleaved-caspase-3 (AF835SP, R&D Systems) and β-actin as loading control (ab8226 ...
-
bioRxiv - Cancer Biology 2022Quote: ... Caspase 3 (R&D Systems AF835, 1:800). The sections were then incubated with appropriate secondary antibodies for 30 minutes at room temperature ...
-
bioRxiv - Bioengineering 2024Quote: ... and 3 mM CHIR99021 (R&D Systems; 4423).
-
bioRxiv - Neuroscience 2023Quote: ... 10 ng/ml Interleukin-3 (R&D Systems), 10 ng/ml Interleukin-6 (R&D Systems) ...
-
bioRxiv - Genomics 2023Quote: ... and NT-3 (20ng/ml, R&D Systems) every two days ...
-
bioRxiv - Cell Biology 2024Quote: ... 3 U/mL erythropoietin (R&D Systems USA), 10 μg/mL insulin (StemCell Technologies) ...
-
bioRxiv - Molecular Biology 2024Quote: ... Siglec-3 Fc chimera protein (R&D Systems), Siglec-4 Fc chimera protein (R&D Systems) ...
-
bioRxiv - Immunology 2024Quote: ... anti-mouse galectin 3 (polyclonal, R&D systems), anti-mouse Rubicon (polyclonal ...
-
bioRxiv - Developmental Biology 2024Quote: ... 10 ng/ml IL-3 (R&D Systems), 50 ng/ml VEGF ...
-
bioRxiv - Immunology 2022Quote: ... NK cells were transferred to a round-bottom 96-well plate and resuspended in complete RPMI supplemented with 25 ng/mL rhIL-2 (R&D Systems, Cat. 202-IL-010). NK cells were then placed into a 37°C incubator ...
-
Nanoparticle-delivered TLR4 and RIG-I agonists enhance immune response to SARS-CoV-2 subunit vaccinebioRxiv - Immunology 2022Quote: ... there were six mice per treatment and control group for a total of 78 mice in thirteen groups: (A) Seven vaccine groups included 1 μg of unformulated SARS-CoV-2 spike protein (R&D Systems, Cat# 10549-CV-100) delivered with adjuvanted NPs ...
-
bioRxiv - Pathology 2020Quote: ... cells of 2 MOI were treated with serum-free media for 24 hours and then media containing TGF-β (20 ng/ml, R&D Systems, Minneapolis, MN, USA) for 72 hours ...
-
bioRxiv - Immunology 2024Quote: ... 2fTGH and HEK293T cells and ELISA was performed according to the manufacturer’s protocols for human IFN-β (R&D systems DY814-05PBL Assay Science 41410-2), human IFN-γ (Biolegend 43104 ...
-
bioRxiv - Physiology 2024Quote: Wild type C57BL/6 10-week-old female mice were treated daily with recombinant tumor necrosis factor-like weak inducer of apoptosis (TWEAK 1237-TW; R&D Systems; 2 ug per mouse) for 4 days followed by a single i.p ...
-
bioRxiv - Cell Biology 2024Quote: ... cells were seeded at 1.5×105/ml in primary differentiation medium supplemented with 1ng/ml interleukin-3 (IL-3, R&D Systems), 10ng/ml SCF and 1μg/ml doxycycline ...
-
bioRxiv - Molecular Biology 2023Quote: Polystyrene microtiter plates were coated with 1 µg/ml recombinant SARS-CoV-2 spike protein produced in HEK293T cells (10549-CV-100, R&D Systems and Biotech, NE, MN, USA) while some plates were coated with 50 ng/ml SARS-CoV-2 S protein RBD or Biotinylated hACE2 (0.2 µg/ml ...
-
bioRxiv - Cancer Biology 2022Quote: ... the cells were starved with 2% FBS media overnight and treated with Activin-A (R&D system, 338-AC-010, 25 ng/mL or 50 ng/mL) for indicated times.
-
bioRxiv - Immunology 2023Quote: ... The remaining NK cells were transferred to a round-bottom 96-well plate and resuspended in complete RPMI supplemented with 25 ng/mL (250 IU/mL) rhIL-2 (R&D Systems, cat. no. 202-IL-010), then placed in a 37C CO2 incubator for 12-16 hours ...
-
bioRxiv - Developmental Biology 2021Quote: ... anti-Oct3/4 (MAB1759, R&D Systems), anti-Sox2 (S1451 ...
-
bioRxiv - Cancer Biology 2020Quote: ... and 4-1BB (MAB9371, R&D systems) 1mg/kg was injected on days 0 and 4 through an intravenous route ...
-
bioRxiv - Immunology 2024Quote: ... mouse IL-4 (#DY404, R&D Systems), and mouse IL-9 (#DY409 ...